CENTRO DE NEUROCIENCIAS E BIOLOGIA CELULAR has a total of 14 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DITESAN LTD, AAL SCIENT INC and APTAHEM AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Nanostructure applications | |
#6 | Special acyclic compounds | |
#7 | Specific use of cosmetics | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Ferreira Pires Cristiana | 6 |
#2 | Ribeiro Lemos Pereira Carlos Filipe | 6 |
#3 | Fiúza Rosa Fábio Alexandre | 4 |
#4 | Da Silva Ferreira Lino | 4 |
#5 | Da Fonseca Miranda Ferreira Lino Miguel Maria | 2 |
#6 | Fernando Cagide Fagin | 2 |
#7 | José Carlos Santos Teixeira | 2 |
#8 | Comune Michela | 2 |
#9 | Fiuza Rosa Fabio Alexandre | 2 |
#10 | Maria Fernanda Martins Borges | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018185709A1 | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof | |
EP3493667A1 | Modular bird cage | |
EP3385373A1 | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof | |
WO2017064687A1 | A composition of gold nanoparticles having antimicrobial peptides bound on their surface for use the treatment of wound healing or in the treatment of ischemic or vascular diseases or in the treatment of skin disorders | |
WO2017064685A1 | A composition for controlled release of a biomolecule, method of preparation and uses thereof |